ATX 0.00% 15.5¢ amplia therapeutics limited

Ann: Additional Patient Response in Pancreatic Cancer Trial, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,242 Posts.
    lightbulb Created with Sketch. 36
    I have edited the graph published by Markwhite above as It deserves a better resolution....music to my ear wink.png

    https://hotcopper.com.au/data/attachments/6366/6366059-7b8923a6ac9dc2cdb503415428611dce.jpg

    If that results can be replicated within the 50 patients cohort ( not yet confirmed I know).... then the sky is the limit for investors AND for the patients responding to the treatments.
    Note that one of the patient responding well is on a 200mg doses ... me like it a lot. smile.png


 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.